#FORMAT=WebAnno TSV 3.2


#Text=[0734] Example 3a, Step 7: Benzyl (S)-1-((1S,2S,4R)-4-(tert-butyldimethyls-ilyloxy)-2-isopropylcyclohexyl)-2-oxopyrrolidin-3-ylcarbamate (1.0 g) was dissolved in a 4/1/1 mixture of AcOH/THF/H.sub.2O (60 mL).
1-1	0-1	[	
1-2	1-5	0734	
1-3	5-6	]	
1-4	7-14	Example	
1-5	15-17	3a	
1-6	17-18	,	
1-7	19-23	Step	
1-8	24-25	7	
1-9	25-26	:	
1-10	27-33	Benzyl	
1-11	34-35	(	
1-12	35-36	S	
1-13	36-37	)	
1-14	37-38	-	
1-15	38-39	1	
1-16	39-40	-	
1-17	40-41	(	
1-18	41-42	(	
1-19	42-44	1S	
1-20	44-45	,	
1-21	45-47	2S	
1-22	47-48	,	
1-23	48-50	4R	
1-24	50-51	)	
1-25	51-52	-	
1-26	52-53	4	
1-27	53-54	-	
1-28	54-55	(	
1-29	55-82	tert-butyldimethyls-ilyloxy	
1-30	82-83	)	
1-31	83-84	-	
1-32	84-85	2	
1-33	85-86	-	
1-34	86-105	isopropylcyclohexyl	
1-35	105-106	)	
1-36	106-107	-	
1-37	107-108	2	
1-38	108-109	-	
1-39	109-122	oxopyrrolidin	
1-40	122-123	-	
1-41	123-124	3	
1-42	124-125	-	
1-43	125-136	ylcarbamate	
1-44	137-138	(	
1-45	138-141	1.0	
1-46	142-143	g	
1-47	143-144	)	
1-48	145-148	was	
1-49	149-158	dissolved	
1-50	159-161	in	
1-51	162-163	a	
1-52	164-165	4	
1-53	165-166	/	
1-54	166-167	1	
1-55	167-168	/	
1-56	168-169	1	
1-57	170-177	mixture	
1-58	178-180	of	
1-59	181-185	AcOH	
1-60	185-186	/	
1-61	186-189	THF	
1-62	189-190	/	
1-63	190-195	H.sub	
1-64	195-198	.2O	
1-65	199-200	(	
1-66	200-202	60	
1-67	203-205	mL	
1-68	205-206	)	
1-69	206-207	.	

#Text=After 72 h, additional 4/1/1 mixture of AcOH/THF/H.sub.2O (30 mL) was added.
2-1	208-213	After	
2-2	214-216	72	
2-3	217-218	h	
2-4	218-219	,	
2-5	220-230	additional	
2-6	231-232	4	
2-7	232-233	/	
2-8	233-234	1	
2-9	234-235	/	
2-10	235-236	1	
2-11	237-244	mixture	
2-12	245-247	of	
2-13	248-252	AcOH	
2-14	252-253	/	
2-15	253-256	THF	
2-16	256-257	/	
2-17	257-262	H.sub	
2-18	262-265	.2O	
2-19	266-267	(	
2-20	267-269	30	
2-21	270-272	mL	
2-22	272-273	)	
2-23	274-277	was	
2-24	278-283	added	
2-25	283-284	.	

#Text=This solution was stirred an additional 24 h before it was concentrated.
3-1	285-289	This	
3-2	290-298	solution	
3-3	299-302	was	
3-4	303-310	stirred	
3-5	311-313	an	
3-6	314-324	additional	
3-7	325-327	24	
3-8	328-329	h	
3-9	330-336	before	
3-10	337-339	it	
3-11	340-343	was	
3-12	344-356	concentrated	
3-13	356-357	.	

#Text=The residue was dissolved in EtOAc and washed with saturated NaHCO.sub.3, dried (MgSO.sub.4), filtered, and concentrated in vacuo to afford benzyl (S)-1-((1S,2S,4R)-4-hydroxy-2-isopropylcyclohexyl)-2-oxopyrrolidin-3-ylca-rbamate (750 mg).
4-1	358-361	The	
4-2	362-369	residue	
4-3	370-373	was	
4-4	374-383	dissolved	
4-5	384-386	in	
4-6	387-392	EtOAc	
4-7	393-396	and	
4-8	397-403	washed	
4-9	404-408	with	
4-10	409-418	saturated	
4-11	419-428	NaHCO.sub	
4-12	428-430	.3	
4-13	430-431	,	
4-14	432-437	dried	
4-15	438-439	(	
4-16	439-447	MgSO.sub	
4-17	447-449	.4	
4-18	449-450	)	
4-19	450-451	,	
4-20	452-460	filtered	
4-21	460-461	,	
4-22	462-465	and	
4-23	466-478	concentrated	
4-24	479-481	in	
4-25	482-487	vacuo	
4-26	488-490	to	
4-27	491-497	afford	
4-28	498-504	benzyl	
4-29	505-506	(	
4-30	506-507	S	
4-31	507-508	)	
4-32	508-509	-	
4-33	509-510	1	
4-34	510-511	-	
4-35	511-512	(	
4-36	512-513	(	
4-37	513-515	1S	
4-38	515-516	,	
4-39	516-518	2S	
4-40	518-519	,	
4-41	519-521	4R	
4-42	521-522	)	
4-43	522-523	-	
4-44	523-524	4	
4-45	524-525	-	
4-46	525-532	hydroxy	
4-47	532-533	-	
4-48	533-534	2	
4-49	534-535	-	
4-50	535-554	isopropylcyclohexyl	
4-51	554-555	)	
4-52	555-556	-	
4-53	556-557	2	
4-54	557-558	-	
4-55	558-571	oxopyrrolidin	
4-56	571-572	-	
4-57	572-573	3	
4-58	573-574	-	
4-59	574-586	ylca-rbamate	
4-60	587-588	(	
4-61	588-591	750	
4-62	592-594	mg	
4-63	594-595	)	
4-64	595-596	.	

#Text=MS found: (M+H).sup.+=375.3.
#Text=[0735] Example 3a, Step 8: Benzyl (S)-1-((1S,2S,4R)-4-hydroxy-2-isopropylc-yclohexyl)-2-oxopyrrolidin-3-ylcarbamate (333 mg) was dissolved in CH.sub.2Cl.sub.2 (5 mL) and cooled to 0.degree.
5-1	597-599	MS	
5-2	600-605	found	
5-3	605-606	:	
5-4	607-608	(	
5-5	608-609	M	
5-6	609-610	+	
5-7	610-611	H	
5-8	611-612	)	
5-9	612-613	.	
5-10	613-616	sup	
5-11	616-617	.	
5-12	617-618	+	
5-13	618-619	=	
5-14	619-624	375.3	
5-15	624-625	.	
5-16	626-627	[	
5-17	627-631	0735	
5-18	631-632	]	
5-19	633-640	Example	
5-20	641-643	3a	
5-21	643-644	,	
5-22	645-649	Step	
5-23	650-651	8	
5-24	651-652	:	
5-25	653-659	Benzyl	
5-26	660-661	(	
5-27	661-662	S	
5-28	662-663	)	
5-29	663-664	-	
5-30	664-665	1	
5-31	665-666	-	
5-32	666-667	(	
5-33	667-668	(	
5-34	668-670	1S	
5-35	670-671	,	
5-36	671-673	2S	
5-37	673-674	,	
5-38	674-676	4R	
5-39	676-677	)	
5-40	677-678	-	
5-41	678-679	4	
5-42	679-680	-	
5-43	680-687	hydroxy	
5-44	687-688	-	
5-45	688-689	2	
5-46	689-690	-	
5-47	690-710	isopropylc-yclohexyl	
5-48	710-711	)	
5-49	711-712	-	
5-50	712-713	2	
5-51	713-714	-	
5-52	714-727	oxopyrrolidin	
5-53	727-728	-	
5-54	728-729	3	
5-55	729-730	-	
5-56	730-741	ylcarbamate	
5-57	742-743	(	
5-58	743-746	333	
5-59	747-749	mg	
5-60	749-750	)	
5-61	751-754	was	
5-62	755-764	dissolved	
5-63	765-767	in	
5-64	768-774	CH.sub	
5-65	774-782	.2Cl.sub	
5-66	782-784	.2	
5-67	785-786	(	
5-68	786-787	5	
5-69	788-790	mL	
5-70	790-791	)	
5-71	792-795	and	
5-72	796-802	cooled	
5-73	803-805	to	
5-74	806-807	0	
5-75	807-808	.	
5-76	808-814	degree	
5-77	814-815	.	

#Text=C. prior to the addition of Dess-Martin reagent (678.9 mg).
6-1	816-817	C	
6-2	817-818	.	
6-3	819-824	prior	
6-4	825-827	to	
6-5	828-831	the	
6-6	832-840	addition	
6-7	841-843	of	
6-8	844-855	Dess-Martin	
6-9	856-863	reagent	
6-10	864-865	(	
6-11	865-870	678.9	
6-12	871-873	mg	
6-13	873-874	)	
6-14	874-875	.	

#Text=This solution was warmed to rt over 1 h, and then was cooled to 0.degree.
7-1	876-880	This	
7-2	881-889	solution	
7-3	890-893	was	
7-4	894-900	warmed	
7-5	901-903	to	
7-6	904-906	rt	
7-7	907-911	over	
7-8	912-913	1	
7-9	914-915	h	
7-10	915-916	,	
7-11	917-920	and	
7-12	921-925	then	
7-13	926-929	was	
7-14	930-936	cooled	
7-15	937-939	to	
7-16	940-941	0	
7-17	941-942	.	
7-18	942-948	degree	
7-19	948-949	.	

#Text=C. prior to the addition of more Dess-Martin reagent (260 mg).
8-1	950-951	C	
8-2	951-952	.	
8-3	953-958	prior	
8-4	959-961	to	
8-5	962-965	the	
8-6	966-974	addition	
8-7	975-977	of	
8-8	978-982	more	
8-9	983-994	Dess-Martin	
8-10	995-1002	reagent	
8-11	1003-1004	(	
8-12	1004-1007	260	
8-13	1008-1010	mg	
8-14	1010-1011	)	
8-15	1011-1012	.	

#Text=After 1 h at rt, the reaction was quenched with Et.sub.2O and 1N NaOH.
9-1	1013-1018	After	
9-2	1019-1020	1	
9-3	1021-1022	h	
9-4	1023-1025	at	
9-5	1026-1028	rt	
9-6	1028-1029	,	
9-7	1030-1033	the	
9-8	1034-1042	reaction	
9-9	1043-1046	was	
9-10	1047-1055	quenched	
9-11	1056-1060	with	
9-12	1061-1067	Et.sub	
9-13	1067-1070	.2O	
9-14	1071-1074	and	
9-15	1075-1077	1N	
9-16	1078-1082	NaOH	
9-17	1082-1083	.	

#Text=The organic extracts were combined, washed with saturated Na.sub.2S.sub.2O.sub.3 and NaHCO.sub.3 solutions, dried (MgSO.sub.4), filtered, and concentrated to afford benzyl (S)-1-((1S,2S)-2-isopropyl-4-oxocyclohexyl)-2-oxopyrrolidin-3-ylcarbamate (350 mg).
10-1	1084-1087	The	
10-2	1088-1095	organic	
10-3	1096-1104	extracts	
10-4	1105-1109	were	
10-5	1110-1118	combined	
10-6	1118-1119	,	
10-7	1120-1126	washed	
10-8	1127-1131	with	
10-9	1132-1141	saturated	
10-10	1142-1148	Na.sub	
10-11	1148-1155	.2S.sub	
10-12	1155-1162	.2O.sub	
10-13	1162-1164	.3	
10-14	1165-1168	and	
10-15	1169-1178	NaHCO.sub	
10-16	1178-1180	.3	
10-17	1181-1190	solutions	
10-18	1190-1191	,	
10-19	1192-1197	dried	
10-20	1198-1199	(	
10-21	1199-1207	MgSO.sub	
10-22	1207-1209	.4	
10-23	1209-1210	)	
10-24	1210-1211	,	
10-25	1212-1220	filtered	
10-26	1220-1221	,	
10-27	1222-1225	and	
10-28	1226-1238	concentrated	
10-29	1239-1241	to	
10-30	1242-1248	afford	
10-31	1249-1255	benzyl	
10-32	1256-1257	(	
10-33	1257-1258	S	
10-34	1258-1259	)	
10-35	1259-1260	-	
10-36	1260-1261	1	
10-37	1261-1262	-	
10-38	1262-1263	(	
10-39	1263-1264	(	
10-40	1264-1266	1S	
10-41	1266-1267	,	
10-42	1267-1269	2S	
10-43	1269-1270	)	
10-44	1270-1271	-	
10-45	1271-1272	2	
10-46	1272-1273	-	
10-47	1273-1282	isopropyl	
10-48	1282-1283	-	
10-49	1283-1284	4	
10-50	1284-1285	-	
10-51	1285-1298	oxocyclohexyl	
10-52	1298-1299	)	
10-53	1299-1300	-	
10-54	1300-1301	2	
10-55	1301-1302	-	
10-56	1302-1315	oxopyrrolidin	
10-57	1315-1316	-	
10-58	1316-1317	3	
10-59	1317-1318	-	
10-60	1318-1329	ylcarbamate	
10-61	1330-1331	(	
10-62	1331-1334	350	
10-63	1335-1337	mg	
10-64	1337-1338	)	
10-65	1338-1339	.	

#Text=MS found: (M+H).sup.+=373.4.
#Text=[0736] Example 3a, Step 9: Benzyl (S)-1-((1S,2S)-2-isopropyl-4-oxocyclohex-yl)-2-oxopyrrolidin-3-ylcarbamate (350 mg) was dissolved in Ti(Oi-Pr).sub.4 (2 mL) prior to the addition of iPr(Me)NH (642 mg).
11-1	1340-1342	MS	
11-2	1343-1348	found	
11-3	1348-1349	:	
11-4	1350-1351	(	
11-5	1351-1352	M	
11-6	1352-1353	+	
11-7	1353-1354	H	
11-8	1354-1355	)	
11-9	1355-1356	.	
11-10	1356-1359	sup	
11-11	1359-1360	.	
11-12	1360-1361	+	
11-13	1361-1362	=	
11-14	1362-1367	373.4	
11-15	1367-1368	.	
11-16	1369-1370	[	
11-17	1370-1374	0736	
11-18	1374-1375	]	
11-19	1376-1383	Example	
11-20	1384-1386	3a	
11-21	1386-1387	,	
11-22	1388-1392	Step	
11-23	1393-1394	9	
11-24	1394-1395	:	
11-25	1396-1402	Benzyl	
11-26	1403-1404	(	
11-27	1404-1405	S	
11-28	1405-1406	)	
11-29	1406-1407	-	
11-30	1407-1408	1	
11-31	1408-1409	-	
11-32	1409-1410	(	
11-33	1410-1411	(	
11-34	1411-1413	1S	
11-35	1413-1414	,	
11-36	1414-1416	2S	
11-37	1416-1417	)	
11-38	1417-1418	-	
11-39	1418-1419	2	
11-40	1419-1420	-	
11-41	1420-1429	isopropyl	
11-42	1429-1430	-	
11-43	1430-1431	4	
11-44	1431-1432	-	
11-45	1432-1446	oxocyclohex-yl	
11-46	1446-1447	)	
11-47	1447-1448	-	
11-48	1448-1449	2	
11-49	1449-1450	-	
11-50	1450-1463	oxopyrrolidin	
11-51	1463-1464	-	
11-52	1464-1465	3	
11-53	1465-1466	-	
11-54	1466-1477	ylcarbamate	
11-55	1478-1479	(	
11-56	1479-1482	350	
11-57	1483-1485	mg	
11-58	1485-1486	)	
11-59	1487-1490	was	
11-60	1491-1500	dissolved	
11-61	1501-1503	in	
11-62	1504-1506	Ti	
11-63	1506-1507	(	
11-64	1507-1512	Oi-Pr	
11-65	1512-1513	)	
11-66	1513-1514	.	
11-67	1514-1517	sub	
11-68	1517-1519	.4	
11-69	1520-1521	(	
11-70	1521-1522	2	
11-71	1523-1525	mL	
11-72	1525-1526	)	
11-73	1527-1532	prior	
11-74	1533-1535	to	
11-75	1536-1539	the	
11-76	1540-1548	addition	
11-77	1549-1551	of	
11-78	1552-1555	iPr	
11-79	1555-1556	(	
11-80	1556-1558	Me	
11-81	1558-1559	)	
11-82	1559-1561	NH	
11-83	1562-1563	(	
11-84	1563-1566	642	
11-85	1567-1569	mg	
11-86	1569-1570	)	
11-87	1570-1571	.	

#Text=After 3 h, this solution was cooled to 0.degree.
12-1	1572-1577	After	
12-2	1578-1579	3	
12-3	1580-1581	h	
12-4	1581-1582	,	
12-5	1583-1587	this	
12-6	1588-1596	solution	
12-7	1597-1600	was	
12-8	1601-1607	cooled	
12-9	1608-1610	to	
12-10	1611-1612	0	
12-11	1612-1613	.	
12-12	1613-1619	degree	
12-13	1619-1620	.	

#Text=C. prior to the addition of MeOH (3 mL) and NaBH.sub.4 (66.8 mg).
13-1	1621-1622	C	
13-2	1622-1623	.	
13-3	1624-1629	prior	
13-4	1630-1632	to	
13-5	1633-1636	the	
13-6	1637-1645	addition	
13-7	1646-1648	of	
13-8	1649-1653	MeOH	
13-9	1654-1655	(	
13-10	1655-1656	3	
13-11	1657-1659	mL	
13-12	1659-1660	)	
13-13	1661-1664	and	
13-14	1665-1673	NaBH.sub	
13-15	1673-1675	.4	
13-16	1676-1677	(	
13-17	1677-1681	66.8	
13-18	1682-1684	mg	
13-19	1684-1685	)	
13-20	1685-1686	.	

#Text=After 1 h at rt, the reaction was quenched with 0.5N NaOH solution and extracted with CH.sub.2Cl.sub.2 (2.times.).
14-1	1687-1692	After	
14-2	1693-1694	1	
14-3	1695-1696	h	
14-4	1697-1699	at	
14-5	1700-1702	rt	
14-6	1702-1703	,	
14-7	1704-1707	the	
14-8	1708-1716	reaction	
14-9	1717-1720	was	
14-10	1721-1729	quenched	
14-11	1730-1734	with	
14-12	1735-1739	0.5N	
14-13	1740-1744	NaOH	
14-14	1745-1753	solution	
14-15	1754-1757	and	
14-16	1758-1767	extracted	
14-17	1768-1772	with	
14-18	1773-1779	CH.sub	
14-19	1779-1787	.2Cl.sub	
14-20	1787-1789	.2	
14-21	1790-1791	(	
14-22	1791-1792	2	
14-23	1792-1793	.	
14-24	1793-1798	times	
14-25	1798-1799	.	
14-26	1799-1800	)	
14-27	1800-1801	.	

#Text=The organic extracts were combined, dried (MgSO.sub.4), filtered, and concentrated to a mixture of diastereomers benzyl (S)-1-((1S,2S,4R/S)-2-isopropyl-4-(isopropyl(methyl)amino)cyclohexyl)-2-o-xopyrrolidin-3-ylcarbamate (162.4 mg).
15-1	1802-1805	The	
15-2	1806-1813	organic	
15-3	1814-1822	extracts	
15-4	1823-1827	were	
15-5	1828-1836	combined	
15-6	1836-1837	,	
15-7	1838-1843	dried	
15-8	1844-1845	(	
15-9	1845-1853	MgSO.sub	
15-10	1853-1855	.4	
15-11	1855-1856	)	
15-12	1856-1857	,	
15-13	1858-1866	filtered	
15-14	1866-1867	,	
15-15	1868-1871	and	
15-16	1872-1884	concentrated	
15-17	1885-1887	to	
15-18	1888-1889	a	
15-19	1890-1897	mixture	
15-20	1898-1900	of	
15-21	1901-1914	diastereomers	
15-22	1915-1921	benzyl	
15-23	1922-1923	(	
15-24	1923-1924	S	
15-25	1924-1925	)	
15-26	1925-1926	-	
15-27	1926-1927	1	
15-28	1927-1928	-	
15-29	1928-1929	(	
15-30	1929-1930	(	
15-31	1930-1932	1S	
15-32	1932-1933	,	
15-33	1933-1935	2S	
15-34	1935-1936	,	
15-35	1936-1938	4R	
15-36	1938-1939	/	
15-37	1939-1940	S	
15-38	1940-1941	)	
15-39	1941-1942	-	
15-40	1942-1943	2	
15-41	1943-1944	-	
15-42	1944-1953	isopropyl	
15-43	1953-1954	-	
15-44	1954-1955	4	
15-45	1955-1956	-	
15-46	1956-1957	(	
15-47	1957-1966	isopropyl	
15-48	1966-1967	(	
15-49	1967-1973	methyl	
15-50	1973-1974	)	
15-51	1974-1979	amino	
15-52	1979-1980	)	
15-53	1980-1990	cyclohexyl	
15-54	1990-1991	)	
15-55	1991-1992	-	
15-56	1992-1993	2	
15-57	1993-1994	-	
15-58	1994-2008	o-xopyrrolidin	
15-59	2008-2009	-	
15-60	2009-2010	3	
15-61	2010-2011	-	
15-62	2011-2022	ylcarbamate	
15-63	2023-2024	(	
15-64	2024-2029	162.4	
15-65	2030-2032	mg	
15-66	2032-2033	)	
15-67	2033-2034	.	

#Text=MS found: (M+H).sup.+=430.5.
#Text=[0737] Example 3a, Step 10: Benzyl (S)-1-((1S,2S,4R/S)-2-isopropyl-4-(isop-ropyl(methyl)amino)cyclohexyl)-2-oxopyrrolidin-3-ylcarbamate (160 mg) was dissolved in MeOH (6 mL) prior to the addition of 20% Pd(OH).sub.2 (50 mg) in a Parr bottle.
16-1	2035-2037	MS	
16-2	2038-2043	found	
16-3	2043-2044	:	
16-4	2045-2046	(	
16-5	2046-2047	M	
16-6	2047-2048	+	
16-7	2048-2049	H	
16-8	2049-2050	)	
16-9	2050-2051	.	
16-10	2051-2054	sup	
16-11	2054-2055	.	
16-12	2055-2056	+	
16-13	2056-2057	=	
16-14	2057-2062	430.5	
16-15	2062-2063	.	
16-16	2064-2065	[	
16-17	2065-2069	0737	
16-18	2069-2070	]	
16-19	2071-2078	Example	
16-20	2079-2081	3a	
16-21	2081-2082	,	
16-22	2083-2087	Step	
16-23	2088-2090	10	
16-24	2090-2091	:	
16-25	2092-2098	Benzyl	
16-26	2099-2100	(	
16-27	2100-2101	S	
16-28	2101-2102	)	
16-29	2102-2103	-	
16-30	2103-2104	1	
16-31	2104-2105	-	
16-32	2105-2106	(	
16-33	2106-2107	(	
16-34	2107-2109	1S	
16-35	2109-2110	,	
16-36	2110-2112	2S	
16-37	2112-2113	,	
16-38	2113-2115	4R	
16-39	2115-2116	/	
16-40	2116-2117	S	
16-41	2117-2118	)	
16-42	2118-2119	-	
16-43	2119-2120	2	
16-44	2120-2121	-	
16-45	2121-2130	isopropyl	
16-46	2130-2131	-	
16-47	2131-2132	4	
16-48	2132-2133	-	
16-49	2133-2134	(	
16-50	2134-2144	isop-ropyl	
16-51	2144-2145	(	
16-52	2145-2151	methyl	
16-53	2151-2152	)	
16-54	2152-2157	amino	
16-55	2157-2158	)	
16-56	2158-2168	cyclohexyl	
16-57	2168-2169	)	
16-58	2169-2170	-	
16-59	2170-2171	2	
16-60	2171-2172	-	
16-61	2172-2185	oxopyrrolidin	
16-62	2185-2186	-	
16-63	2186-2187	3	
16-64	2187-2188	-	
16-65	2188-2199	ylcarbamate	
16-66	2200-2201	(	
16-67	2201-2204	160	
16-68	2205-2207	mg	
16-69	2207-2208	)	
16-70	2209-2212	was	
16-71	2213-2222	dissolved	
16-72	2223-2225	in	
16-73	2226-2230	MeOH	
16-74	2231-2232	(	
16-75	2232-2233	6	
16-76	2234-2236	mL	
16-77	2236-2237	)	
16-78	2238-2243	prior	
16-79	2244-2246	to	
16-80	2247-2250	the	
16-81	2251-2259	addition	
16-82	2260-2262	of	
16-83	2263-2266	20%	
16-84	2267-2269	Pd	
16-85	2269-2270	(	
16-86	2270-2272	OH	
16-87	2272-2273	)	
16-88	2273-2274	.	
16-89	2274-2277	sub	
16-90	2277-2279	.2	
16-91	2280-2281	(	
16-92	2281-2283	50	
16-93	2284-2286	mg	
16-94	2286-2287	)	
16-95	2288-2290	in	
16-96	2291-2292	a	
16-97	2293-2297	Parr	
16-98	2298-2304	bottle	
16-99	2304-2305	.	

#Text=The bottle was evacuated and then back-filled with hydrogen; this was repeated three more times.
17-1	2306-2309	The	
17-2	2310-2316	bottle	
17-3	2317-2320	was	
17-4	2321-2330	evacuated	
17-5	2331-2334	and	
17-6	2335-2339	then	
17-7	2340-2351	back-filled	
17-8	2352-2356	with	
17-9	2357-2365	hydrogen	
17-10	2365-2366	;	
17-11	2367-2371	this	
17-12	2372-2375	was	
17-13	2376-2384	repeated	
17-14	2385-2390	three	
17-15	2391-2395	more	
17-16	2396-2401	times	
17-17	2401-2402	.	

#Text=The reaction was stirred under 60 psi of H.sub.2 for 5 h and then filtered and concentrated.
18-1	2403-2406	The	
18-2	2407-2415	reaction	
18-3	2416-2419	was	
18-4	2420-2427	stirred	
18-5	2428-2433	under	
18-6	2434-2436	60	
18-7	2437-2440	psi	
18-8	2441-2443	of	
18-9	2444-2449	H.sub	
18-10	2449-2451	.2	
18-11	2452-2455	for	
18-12	2456-2457	5	
18-13	2458-2459	h	
18-14	2460-2463	and	
18-15	2464-2468	then	
18-16	2469-2477	filtered	
18-17	2478-2481	and	
18-18	2482-2494	concentrated	
18-19	2494-2495	.	

#Text=The resulting residue was dissolved in MeOH (6 mL) prior to the addition of 20% Pd(OH).sub.2 (75 mg) in a Parr bottle.
19-1	2496-2499	The	
19-2	2500-2509	resulting	
19-3	2510-2517	residue	
19-4	2518-2521	was	
19-5	2522-2531	dissolved	
19-6	2532-2534	in	
19-7	2535-2539	MeOH	
19-8	2540-2541	(	
19-9	2541-2542	6	
19-10	2543-2545	mL	
19-11	2545-2546	)	
19-12	2547-2552	prior	
19-13	2553-2555	to	
19-14	2556-2559	the	
19-15	2560-2568	addition	
19-16	2569-2571	of	
19-17	2572-2575	20%	
19-18	2576-2578	Pd	
19-19	2578-2579	(	
19-20	2579-2581	OH	
19-21	2581-2582	)	
19-22	2582-2583	.	
19-23	2583-2586	sub	
19-24	2586-2588	.2	
19-25	2589-2590	(	
19-26	2590-2592	75	
19-27	2593-2595	mg	
19-28	2595-2596	)	
19-29	2597-2599	in	
19-30	2600-2601	a	
19-31	2602-2606	Parr	
19-32	2607-2613	bottle	
19-33	2613-2614	.	

#Text=The bottle was evacuated and then back-filled with hydrogen; this was repeated three more times.
20-1	2615-2618	The	
20-2	2619-2625	bottle	
20-3	2626-2629	was	
20-4	2630-2639	evacuated	
20-5	2640-2643	and	
20-6	2644-2648	then	
20-7	2649-2660	back-filled	
20-8	2661-2665	with	
20-9	2666-2674	hydrogen	
20-10	2674-2675	;	
20-11	2676-2680	this	
20-12	2681-2684	was	
20-13	2685-2693	repeated	
20-14	2694-2699	three	
20-15	2700-2704	more	
20-16	2705-2710	times	
20-17	2710-2711	.	

#Text=The reaction was stirred under 50 psi of H.sub.2 for 24 h and then filtered and concentrated to provide (S)-3-amino-1-((1S,2S,4R/S)-2-isopropyl-4-(is-opropyl(methyl)amino)cyclohexyl)pyrrolidin-2-one (101 mg).
21-1	2712-2715	The	
21-2	2716-2724	reaction	
21-3	2725-2728	was	
21-4	2729-2736	stirred	
21-5	2737-2742	under	
21-6	2743-2745	50	
21-7	2746-2749	psi	
21-8	2750-2752	of	
21-9	2753-2758	H.sub	
21-10	2758-2760	.2	
21-11	2761-2764	for	
21-12	2765-2767	24	
21-13	2768-2769	h	
21-14	2770-2773	and	
21-15	2774-2778	then	
21-16	2779-2787	filtered	
21-17	2788-2791	and	
21-18	2792-2804	concentrated	
21-19	2805-2807	to	
21-20	2808-2815	provide	
21-21	2816-2817	(	
21-22	2817-2818	S	
21-23	2818-2819	)	
21-24	2819-2820	-	
21-25	2820-2821	3	
21-26	2821-2822	-	
21-27	2822-2827	amino	
21-28	2827-2828	-	
21-29	2828-2829	1	
21-30	2829-2830	-	
21-31	2830-2831	(	
21-32	2831-2832	(	
21-33	2832-2834	1S	
21-34	2834-2835	,	
21-35	2835-2837	2S	
21-36	2837-2838	,	
21-37	2838-2840	4R	
21-38	2840-2841	/	
21-39	2841-2842	S	
21-40	2842-2843	)	
21-41	2843-2844	-	
21-42	2844-2845	2	
21-43	2845-2846	-	
21-44	2846-2855	isopropyl	
21-45	2855-2856	-	
21-46	2856-2857	4	
21-47	2857-2858	-	
21-48	2858-2859	(	
21-49	2859-2869	is-opropyl	
21-50	2869-2870	(	
21-51	2870-2876	methyl	
21-52	2876-2877	)	
21-53	2877-2882	amino	
21-54	2882-2883	)	
21-55	2883-2893	cyclohexyl	
21-56	2893-2894	)	
21-57	2894-2904	pyrrolidin	
21-58	2904-2905	-	
21-59	2905-2906	2	
21-60	2906-2907	-	
21-61	2907-2910	one	
21-62	2911-2912	(	
21-63	2912-2915	101	
21-64	2916-2918	mg	
21-65	2918-2919	)	
21-66	2919-2920	.	

#Text=MS (ES+)=296.3 (M+H).sup.+.
#Text=[0738] Example 3a, Step 11: To a solution of (S)-3-amino-1-((1S,2S,4R/S)-2--isopropyl-4-(isopropyl(methyl)amino)cyclohexyl)pyrrolidin-2-one (85 mg) in EtOH (2.5 mL) was added triethylamine (0.2 mL) and 4-chloro-6-(trifluoromethyl)quinazoline (100.1 mg).
22-1	2921-2923	MS	
22-2	2924-2925	(	
22-3	2925-2927	ES	
22-4	2927-2928	+	
22-5	2928-2929	)	
22-6	2929-2930	=	
22-7	2930-2935	296.3	
22-8	2936-2937	(	
22-9	2937-2938	M	
22-10	2938-2939	+	
22-11	2939-2940	H	
22-12	2940-2941	)	
22-13	2941-2942	.	
22-14	2942-2945	sup	
22-15	2945-2946	.	
22-16	2946-2947	+	
22-17	2947-2948	.	
22-18	2949-2950	[	
22-19	2950-2954	0738	
22-20	2954-2955	]	
22-21	2956-2963	Example	
22-22	2964-2966	3a	
22-23	2966-2967	,	
22-24	2968-2972	Step	
22-25	2973-2975	11	
22-26	2975-2976	:	
22-27	2977-2979	To	
22-28	2980-2981	a	
22-29	2982-2990	solution	
22-30	2991-2993	of	
22-31	2994-2995	(	
22-32	2995-2996	S	
22-33	2996-2997	)	
22-34	2997-2998	-	
22-35	2998-2999	3	
22-36	2999-3000	-	
22-37	3000-3005	amino	
22-38	3005-3006	-	
22-39	3006-3007	1	
22-40	3007-3008	-	
22-41	3008-3009	(	
22-42	3009-3010	(	
22-43	3010-3012	1S	
22-44	3012-3013	,	
22-45	3013-3015	2S	
22-46	3015-3016	,	
22-47	3016-3018	4R	
22-48	3018-3019	/	
22-49	3019-3020	S	
22-50	3020-3021	)	
22-51	3021-3022	-	
22-52	3022-3023	2	
22-53	3023-3024	-	
22-54	3024-3025	-	
22-55	3025-3034	isopropyl	
22-56	3034-3035	-	
22-57	3035-3036	4	
22-58	3036-3037	-	
22-59	3037-3038	(	
22-60	3038-3047	isopropyl	
22-61	3047-3048	(	
22-62	3048-3054	methyl	
22-63	3054-3055	)	
22-64	3055-3060	amino	
22-65	3060-3061	)	
22-66	3061-3071	cyclohexyl	
22-67	3071-3072	)	
22-68	3072-3082	pyrrolidin	
22-69	3082-3083	-	
22-70	3083-3084	2	
22-71	3084-3085	-	
22-72	3085-3088	one	
22-73	3089-3090	(	
22-74	3090-3092	85	
22-75	3093-3095	mg	
22-76	3095-3096	)	
22-77	3097-3099	in	
22-78	3100-3104	EtOH	
22-79	3105-3106	(	
22-80	3106-3109	2.5	
22-81	3110-3112	mL	
22-82	3112-3113	)	
22-83	3114-3117	was	
22-84	3118-3123	added	
22-85	3124-3137	triethylamine	
22-86	3138-3139	(	
22-87	3139-3142	0.2	
22-88	3143-3145	mL	
22-89	3145-3146	)	
22-90	3147-3150	and	
22-91	3151-3152	4	
22-92	3152-3153	-	
22-93	3153-3159	chloro	
22-94	3159-3160	-	
22-95	3160-3161	6	
22-96	3161-3162	-	
22-97	3162-3163	(	
22-98	3163-3178	trifluoromethyl	
22-99	3178-3179	)	
22-100	3179-3190	quinazoline	
22-101	3191-3192	(	
22-102	3192-3197	100.1	
22-103	3198-3200	mg	
22-104	3200-3201	)	
22-105	3201-3202	.	

#Text=The mixture was heated at 80.degree.
23-1	3203-3206	The	
23-2	3207-3214	mixture	
23-3	3215-3218	was	
23-4	3219-3225	heated	
23-5	3226-3228	at	
23-6	3229-3231	80	
23-7	3231-3232	.	
23-8	3232-3238	degree	
23-9	3238-3239	.	

#Text=C. for 14 h before it was filtered and concentrated in vacuo.
24-1	3240-3241	C	
24-2	3241-3242	.	
24-3	3243-3246	for	
24-4	3247-3249	14	
24-5	3250-3251	h	
24-6	3252-3258	before	
24-7	3259-3261	it	
24-8	3262-3265	was	
24-9	3266-3274	filtered	
24-10	3275-3278	and	
24-11	3279-3291	concentrated	
24-12	3292-3294	in	
24-13	3295-3300	vacuo	
24-14	3300-3301	.	

#Text=The residue was purified by chiral chromatography (AD column, EtOH as mobile phase) to afford (S)-1-((1S,2S,4R)-2-isopropyl-4-(isopropy-l(methyl)amino)cyclohexyl)-3-(6-(trifluoromethyl)quinazolin-4-ylamino)pyrr-olidin-2-one [52 mg; MS found: (M+H).sup.+=492.4] and (S)-1-((1S,2S,4S)-2-isopropyl-4-(isopropyl(methyl)amino)cyclohexyl)-3-(6--(trifluoromethyl)quinazolin-4-ylamino)pyrrolidin-2-one [8 mg; MS found: (M+H).sup.+=492.4].
25-1	3302-3305	The	
25-2	3306-3313	residue	
25-3	3314-3317	was	
25-4	3318-3326	purified	
25-5	3327-3329	by	
25-6	3330-3336	chiral	
25-7	3337-3351	chromatography	
25-8	3352-3353	(	
25-9	3353-3355	AD	
25-10	3356-3362	column	
25-11	3362-3363	,	
25-12	3364-3368	EtOH	
25-13	3369-3371	as	
25-14	3372-3378	mobile	
25-15	3379-3384	phase	
25-16	3384-3385	)	
25-17	3386-3388	to	
25-18	3389-3395	afford	
25-19	3396-3397	(	
25-20	3397-3398	S	
25-21	3398-3399	)	
25-22	3399-3400	-	
25-23	3400-3401	1	
25-24	3401-3402	-	
25-25	3402-3403	(	
25-26	3403-3404	(	
25-27	3404-3406	1S	
25-28	3406-3407	,	
25-29	3407-3409	2S	
25-30	3409-3410	,	
25-31	3410-3412	4R	
25-32	3412-3413	)	
25-33	3413-3414	-	
25-34	3414-3415	2	
25-35	3415-3416	-	
25-36	3416-3425	isopropyl	
25-37	3425-3426	-	
25-38	3426-3427	4	
25-39	3427-3428	-	
25-40	3428-3429	(	
25-41	3429-3439	isopropy-l	
25-42	3439-3440	(	
25-43	3440-3446	methyl	
25-44	3446-3447	)	
25-45	3447-3452	amino	
25-46	3452-3453	)	
25-47	3453-3463	cyclohexyl	
25-48	3463-3464	)	
25-49	3464-3465	-	
25-50	3465-3466	3	
25-51	3466-3467	-	
25-52	3467-3468	(	
25-53	3468-3469	6	
25-54	3469-3470	-	
25-55	3470-3471	(	
25-56	3471-3486	trifluoromethyl	
25-57	3486-3487	)	
25-58	3487-3497	quinazolin	
25-59	3497-3498	-	
25-60	3498-3499	4	
25-61	3499-3500	-	
25-62	3500-3507	ylamino	
25-63	3507-3508	)	
25-64	3508-3519	pyrr-olidin	
25-65	3519-3520	-	
25-66	3520-3521	2	
25-67	3521-3522	-	
25-68	3522-3525	one	
25-69	3526-3527	[	
25-70	3527-3529	52	
25-71	3530-3532	mg	
25-72	3532-3533	;	
25-73	3534-3536	MS	
25-74	3537-3542	found	
25-75	3542-3543	:	
25-76	3544-3545	(	
25-77	3545-3546	M	
25-78	3546-3547	+	
25-79	3547-3548	H	
25-80	3548-3549	)	
25-81	3549-3550	.	
25-82	3550-3553	sup	
25-83	3553-3554	.	
25-84	3554-3555	+	
25-85	3555-3556	=	
25-86	3556-3561	492.4	
25-87	3561-3562	]	
25-88	3563-3566	and	
25-89	3567-3568	(	
25-90	3568-3569	S	
25-91	3569-3570	)	
25-92	3570-3571	-	
25-93	3571-3572	1	
25-94	3572-3573	-	
25-95	3573-3574	(	
25-96	3574-3575	(	
25-97	3575-3577	1S	
25-98	3577-3578	,	
25-99	3578-3580	2S	
25-100	3580-3581	,	
25-101	3581-3583	4S	
25-102	3583-3584	)	
25-103	3584-3585	-	
25-104	3585-3586	2	
25-105	3586-3587	-	
25-106	3587-3596	isopropyl	
25-107	3596-3597	-	
25-108	3597-3598	4	
25-109	3598-3599	-	
25-110	3599-3600	(	
25-111	3600-3609	isopropyl	
25-112	3609-3610	(	
25-113	3610-3616	methyl	
25-114	3616-3617	)	
25-115	3617-3622	amino	
25-116	3622-3623	)	
25-117	3623-3633	cyclohexyl	
25-118	3633-3634	)	
25-119	3634-3635	-	
25-120	3635-3636	3	
25-121	3636-3637	-	
25-122	3637-3638	(	
25-123	3638-3639	6	
25-124	3639-3640	-	
25-125	3640-3641	-	
25-126	3641-3642	(	
25-127	3642-3657	trifluoromethyl	
25-128	3657-3658	)	
25-129	3658-3668	quinazolin	
25-130	3668-3669	-	
25-131	3669-3670	4	
25-132	3670-3671	-	
25-133	3671-3678	ylamino	
25-134	3678-3679	)	
25-135	3679-3689	pyrrolidin	
25-136	3689-3690	-	
25-137	3690-3691	2	
25-138	3691-3692	-	
25-139	3692-3695	one	
25-140	3696-3697	[	
25-141	3697-3698	8	
25-142	3699-3701	mg	
25-143	3701-3702	;	
25-144	3703-3705	MS	
25-145	3706-3711	found	
25-146	3711-3712	:	
25-147	3713-3714	(	
25-148	3714-3715	M	
25-149	3715-3716	+	
25-150	3716-3717	H	
25-151	3717-3718	)	
25-152	3718-3719	.	
25-153	3719-3722	sup	
25-154	3722-3723	.	
25-155	3723-3724	+	
25-156	3724-3725	=	
25-157	3725-3730	492.4	
25-158	3730-3731	]	
25-159	3731-3732	.	
